(Q45919209)

17 December 2017

title

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. (English)

1 reference

17 December 2017

1 reference

Alexandra E Hoeh

1

1 reference

17 December 2017

Thomas Ach

2

1 reference

17 December 2017

Karen B Schaal

3

1 reference

17 December 2017

Alexander F Scheuerle

4

1 reference

17 December 2017

Stefan Dithmar

5

1 reference

17 December 2017

publication date

26 July 2009

1 reference

17 December 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

17 December 2017

volume

247

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

1635-1641

1 reference

17 December 2017

Macular grid photocoagulation for macular edema in central retinal vein occlusion

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00417-009-1151-1

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

1 reference

12 December 2020

Surgical treatment of central retinal vein occlusion

1 reference

12 December 2020

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

1 reference

12 December 2020

Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.

1 reference

12 December 2020

Bevacizumab in retinal vein occlusion-results of a prospective case series

1 reference

12 December 2020

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

1 reference

12 December 2020

Central and branch retinal vein occlusion. Current strategies for treatment in Germany, Austria and Switzerland

1 reference

12 December 2020

Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group

1 reference

12 December 2020

Analysis of visual prognosis and correlative factors in retinal vein occlusion

1 reference

12 December 2020

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

12 December 2020

[Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]

1 reference

12 December 2020

Vascular endothelial growth factor upregulation in human central retinal vein occlusion

1 reference

12 December 2020

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

1 reference

12 December 2020

[Visual prognosis of branch retinal vein occlusion with macular edema].

1 reference

12 December 2020

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

1 reference

12 December 2020

Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion

1 reference

12 December 2020

OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion

1 reference

12 December 2020

10.1007/S00417-009-1151-1

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1009347447

0 references

1 reference

17 December 2017